Free Trial
NASDAQ:STSS

Sharps Technology Q2 2025 Earnings Report

Sharps Technology logo
$13.55 -2.48 (-15.47%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$13.08 -0.48 (-3.51%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sharps Technology EPS Results

Actual EPS
$3.58
Consensus EPS
-$0.94
Beat/Miss
Beat by +$4.52
One Year Ago EPS
N/A

Sharps Technology Revenue Results

Actual Revenue
$0.22 million
Expected Revenue
$0.25 million
Beat/Miss
Missed by -$27.00 thousand
YoY Revenue Growth
N/A

Sharps Technology Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Wednesday, August 13, 2025
Conference Call Time
7:00AM ET

Earnings Documents

Sharps Technology Earnings Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
See More Sharps Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sharps Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sharps Technology and other key companies, straight to your email.

About Sharps Technology

Sharps Technology (NASDAQ:STSS), a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

View Sharps Technology Profile

More Earnings Resources from MarketBeat